Current position:Home >Product >
N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-2,2-diphenyl-ethanamide
N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-2,2-diphenyl-ethanamide
|
|
Canonical SMILES:
CC1(COC2=C(C=CC(=C2)NC(=O)C(C3=CC=CC=C3)C4=CC=CC=C4)N(C1=O)CC=C)C
Isomeric SMILES
CC1(COC2=C(C=CC(=C2)NC(=O)C(C3=CC=CC=C3)C4=CC=CC=C4)N(C1=O)CC=C)C
InChI
InChI=1S/C28H28N2O3/c1-4-17-30-23-16-15-22(18-24(23)33-19-28(2,3)27(30)32)29-26(31)25(20-11-7-5-8-12-20)21-13-9-6-10-14-21/h4-16,18,25H,1,17,19H2,2-3H3,(H,29,31)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-4-phenoxy-benzamide
- N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-3-(phenylsulfonyl)propanamide
- 2-(4-chloranylphenoxy)-N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-2-methyl-propanamide
- N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-1-(4-methylphenyl)-5-oxidanylidene-pyrrolidine-3-carboxamide
- N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-8-methoxy-2-oxidanylidene-chromene-3-carboxamide
- N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-1-(4-fluorophenyl)-5-oxidanylidene-pyrrolidine-3-carboxamide
- 1-(4-chlorophenyl)-N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)cyclopentane-1-carboxamide
- N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-9H-xanthene-9-carboxamide
- N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-3,3-diphenyl-propanamide
- N-(3,3-dimethyl-4-oxidanylidene-5-prop-2-enyl-2H-1,5-benzoxazepin-8-yl)-4-(dimethylsulfamoyl)benzamide

